The Annexure

News to 23 October 2026 ·

What the ground filed.

A desk of BSE disclosures — every listed company, sliced the way you need it.

Data as of 23 October 2026

Fundraising

Regarding non approval of proposed preferential issue of convertible warrants and request for closure of application for ....

The filing

Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding non approval of proposed preferential issue of convertible warrants and request for closure of application for ....

Company
Choksi Laboratories Ltd · BSE 526546
Filed
19 October 2026, 12:54 IST
BSE category
Company Update / Preferential Issue
Tag
Fundraising · selected
Source
Open the filing on BSE →

Why it led

  • First Fundraising from this company — not seen in the 103 trading days on record
  • Micro cap

Selected by the ranker from 48 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

299 of 86,978 filings in the published window carry Fundraising · 0.34%

Around it

Also filed by Choksi Laboratories Ltd on 19 October 2026

Most recent filings from Choksi Laboratories Ltd

The company

Choksi Laboratories Ltd

BSE 526546 · NSE CHOKSILA · ISIN INE493D01013 · Group X · Active

Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider

Full figures, price and filing history for Choksi Laboratories Ltd →